Second Irregularity In NSABP Data Found; Fisher Takes Leave As Group’s Chairman
In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post
NCI Promises Strong Monitoring Process Visco Calls For Independent Review; Rep. Dingell Plans Hearing April 13
Biotech Organization Endorses Measures On Orphan Drug Act
Salick Signs contract for Fixed-Price Oncology Services
DCE Advisors OK RFAs In Occupational Cancer, H. Pylori
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Jonathan Friedberg tells us how he built a cancer center in an underserved area of New York State
- The insinuation that AstroTurf causes GBM has no basis in science
The Philadelphia Inquirer series does disservice to brain tumor community
